Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.21
-0.76 (-4.23%)
At close: Mar 20, 2026, 4:00 PM EDT
17.52
+0.31 (1.78%)
After-hours: Mar 20, 2026, 7:54 PM EDT
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$31.65
Upside
+83.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | +80.13% | Mar 18, 2026 |
| Roth Capital | Roth Capital | Strong Sell → Strong Buy Initiates $31 | Strong Sell → Strong Buy | Initiates | $31 | +80.13% | Mar 13, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +114.99% | Mar 5, 2026 |
| Mizuho | Mizuho | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | +16.21% | Mar 5, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $44 | Strong Buy | Maintains | $45 → $44 | +155.67% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $21 | Hold | Maintains | $22 → $21 | +22.02% | Feb 25, 2026 |
| Wedbush | Wedbush | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | +4.59% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $48 | Strong Buy | Maintains | $45 → $48 | +178.91% | Feb 25, 2026 |
| Barclays | Barclays | Hold Initiates $24 | Hold | Initiates | $24 | +39.45% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $28 | Hold → Strong Buy | Upgrades | $28 | +62.70% | Jan 21, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $29 → $26 | Buy | Maintains | $29 → $26 | +51.07% | Jan 20, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $39 → $35 | Buy | Maintains | $39 → $35 | +103.37% | Jan 13, 2026 |
| Needham | Needham | Strong Buy Maintains $29 → $28 | Strong Buy | Maintains | $29 → $28 | +62.70% | Jan 13, 2026 |
| Stifel | Stifel | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +178.91% | Dec 19, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $36 | Buy | Maintains | $40 → $36 | +109.18% | Nov 5, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.